Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
EASIER: A new model for online learning of minimally invasive surgery skills.
Oropesa I, Sánchez-Peralta LF, Guzmán García C, Chmarra MK, Berner-Juhos K, Tiu C, Mettouris C, Papadopoulos GA, Papadopoulos A, Blas Pagador J, Post J, Dankelman J, González-Segura A, Sánchez-Margallo FM, Gómez EJ; EASIER Task Force. Oropesa I, et al. Among authors: tiu c. Int J Med Inform. 2023 Dec;180:105269. doi: 10.1016/j.ijmedinf.2023.105269. Epub 2023 Oct 24. Int J Med Inform. 2023. PMID: 37907015
Liver Phantoms Cast in 3D-Printed Mold for Image-Guided Procedures.
Elisei RC, Graur F, Melzer A, Moldovan SC, Tiu C, Popa C, Mois E, Pisla D, Vaida C, Ștefănescu H, Coțe A, Al-Hajjar N. Elisei RC, et al. Among authors: tiu c. Diagnostics (Basel). 2024 Jul 15;14(14):1521. doi: 10.3390/diagnostics14141521. Diagnostics (Basel). 2024. PMID: 39061658 Free PMC article.
Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials.
Montalban X, Vermersch P, Arnold DL, Bar-Or A, Cree BAC, Cross AH, Kubala Havrdova E, Kappos L, Stuve O, Wiendl H, Wolinsky JS, Dahlke F, Le Bolay C, Shen Loo L, Gopalakrishnan S, Hyvert Y, Javor A, Guehring H, Tenenbaum N, Tomic D; evolutionRMS investigators. Montalban X, et al. Lancet Neurol. 2024 Nov;23(11):1119-1132. doi: 10.1016/S1474-4422(24)00328-4. Epub 2024 Sep 19. Lancet Neurol. 2024. PMID: 39307151 Clinical Trial.
A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death.
Mannion J, Gifford V, Bellenie B, Fernando W, Ramos Garcia L, Wilson R, John SW, Udainiya S, Patin EC, Tiu C, Smith A, Goicoechea M, Craxton A, Moraes de Vasconcelos N, Guppy N, Cheung KJ, Cundy NJ, Pierrat O, Brennan A, Roumeliotis TI, Benstead-Hume G, Alexander J, Muirhead G, Layzell S, Lyu W, Roulstone V, Allen M, Baldock H, Legrand A, Gabel F, Serrano-Aparicio N, Starling C, Guo H, Upton J, Gyrd-Hansen M, MacFarlane M, Seddon B, Raynaud F, Roxanis I, Harrington K, Haider S, Choudhary JS, Hoelder S, Tenev T, Meier P. Mannion J, et al. Among authors: tiu c. Immunity. 2024 Jul 9;57(7):1514-1532.e15. doi: 10.1016/j.immuni.2024.04.025. Epub 2024 May 23. Immunity. 2024. PMID: 38788712 Free article.
Levodopa-Carbidopa-Entacapone Intestinal Gel in Advanced Parkinson Disease: A Multicenter Real-Life Experience.
Szász JA, Dulamea AO, Constantin VA, Mureşanu DF, Dumbravă LP, Tiu C, Jianu DC, Simu M, Ene A, Axelerad A, Falup-Pecurariu C, Lungu M, Danci AG, Sabau M, Strilciuc Ş, Popescu BO. Szász JA, et al. Among authors: tiu c. Am J Ther. 2024 May-Jun 01;31(3):e209-e218. doi: 10.1097/MJT.0000000000001707. Epub 2024 Mar 8. Am J Ther. 2024. PMID: 38460175
256 results